THR-123

N/A

Report date: 2025/07/16 17:36:32
NME

Base Information

Drug NameTHR-123
Drug Alias NameTHR-123
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionBone morphogenetic protein receptor type-1A stimulants
TargetsBone morphogenetic protein receptor type-1A
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Miami Miller School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Miami Miller School of Medicine
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A